Company Filing History:
Years Active: 2022
Title: Sunmee Choi: Innovator in Genome Engineering
Introduction
Sunmee Choi is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of genome engineering, particularly through his innovative approaches to enhancing CRISPR-Cas enzymes. His work focuses on increasing mutation efficiency and homologous recombination rates, which are crucial for advancements in genetic research and applications.
Latest Patents
Sunmee Choi holds a patent for "Chimeric genome engineering molecules and methods." This patent provides compositions and methods designed to improve the functionality of site-specific endonucleases. The disclosed compositions include a chimeric polypeptide that combines a site-specific endonuclease or a domain thereof with a functional moiety. The inventions aim to enhance the performance of CRISPR-Cas enzymes, offering potential variants and improvements for future applications.
Career Highlights
Throughout his career, Sunmee Choi has worked with notable organizations, including Gflas Life Sciences, Inc. and Seoul National University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in genome engineering.
Collaborations
Sunmee Choi has collaborated with talented individuals such as Jongjin Park and Ji Young Yoon. These partnerships have fostered a creative environment for innovation and have led to significant advancements in their shared research interests.
Conclusion
Sunmee Choi is a key figure in the realm of genome engineering, with a focus on enhancing CRISPR-Cas technologies. His patent and collaborative efforts reflect his commitment to advancing genetic research and its applications.